The REMAR (Rhein-Main-Registry) real-world study: prospective evaluation of the 21-gene breast recurrence score® assay in addition to Ki-67 for adjuvant treatment decisions in early-stage breast cancer
| Title: | The REMAR (Rhein-Main-Registry) real-world study: prospective evaluation of the 21-gene breast recurrence score® assay in addition to Ki-67 for adjuvant treatment decisions in early-stage breast cancer |
|---|---|
| Authors: | Jackisch, ChristianAff1, Aff2, Aff19, IDs1054902407390y_cor1; Anastasiadou, LouizaAff3; Aulmann, SebastianAff4; Argyriadis, AthanasiosAff1; Möbus, VolkerAff2, Aff5; Solbach, ChristineAff2, Aff6; Baier, PeterAff7; Giesecke, DagmarAff8; Ackermann, SvenAff9; Schulmeyer, ElkeAff10; Gabriel, BorisAff11; Mosch, DietrichAff12; Buchen, StephanieAff2, Aff13; Krapfl, EckartAff2, Aff14; Hurst, UrsulaAff15; Vescia, MarioAff16; Tesch, HansAff2, Aff17; Thill, MarcAff2, Aff18 |
| Source: | Breast Cancer Research and Treatment. 207(2):263-274 |
| Database: | Springer Nature Journals |